Praziquantel, Pyrantel Embonate

Verify with FDA CVM →

29 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
29
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Praziquantel, Pyrantel Embonate

Administration Routes

OralUnknown

Species Affected

Dog 15
Cat 14

Most Affected Breeds

Cat (unknown) 7
Domestic Shorthair 5
Hound - Basset 3
Domestic Longhair 2
Chinese Crested Dog (unspecified) 1
Retriever - Labrador 1
Hound (unspecified) 1
Spitz - German Pomeranian 1
Papillon - Spaniel - Continental Toy (with erect ears or with dropped ears (Phaléne)) 1
Shepherd Dog - Australian 1

Most Reported Reactions

Lack of efficacy (endoparasite) - hookworm 5
Vomiting 4
Lack of efficacy (endoparasite) - tapeworm 4
Behavioural disorder NOS 4
Lack of efficacy (endoparasite) - heartworm 3
Lack of efficacy (ectoparasite) - flea 3
Drug administration error 3
Ataxia 3
Licking 2
Not eating 2
Appetite disorder NOS 2
Lack of efficacy (endoparasite) - roundworm NOS 1

Outcome Breakdown

Outcome Unknown
18 (62.1%)
Ongoing
6 (20.7%)
Recovered/Normal
5 (17.2%)

Data Summary

Metric Value
Total adverse event reports 29
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 2
Distinct breeds in reports 16
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Praziquantel, Pyrantel Embonate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 29 adverse event reports referencing Praziquantel, Pyrantel Embonate, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Praziquantel, Pyrantel Embonate. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Praziquantel, Pyrantel Embonate reports are Dog (15 reports), Cat (14 reports), with Dog accounting for the largest share. Within those species, Cat (unknown) (7), Domestic Shorthair (5), Hound - Basset (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Praziquantel, Pyrantel Embonate are Lack of efficacy (endoparasite) - hookworm (5), Vomiting (4), Lack of efficacy (endoparasite) - tapeworm (4), Behavioural disorder NOS (4). Of the 29 reports with a coded outcome, Outcome Unknown is the leading category at 62.1%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Praziquantel, Pyrantel Embonate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial